{"transactions":[{"id":754550,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":225000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754549,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":402500,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754548,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":402500,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754547,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":125000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754546,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":500000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754545,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":500000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754544,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":450000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754543,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":400000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754542,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":200000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754541,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754540,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.37,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754539,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754538,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.6,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754537,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.33,"expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754536,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754535,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754534,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754533,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":931119,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T21:40:58.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 23, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":750000,"derivative":{"exercise_price":2.06,"expiration_date":"2036-01-23","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001610717-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000027/form4.xml","form_type":"4"}},{"id":931118,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-26T21:40:58.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":1048235,"source":{"system":"sec-edgar","filing":"0001610717-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000027/form4.xml","form_type":"4"}},{"id":933345,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-23T01:50:01.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11839,"price":1.55,"value":18350.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":673235,"source":{"system":"sec-edgar","filing":"0001610717-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000016/form4.xml","form_type":"4"}},{"id":1153631,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-09T21:58:02.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":0.9462,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001610717-25-000116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000116/form4.xml","form_type":"4"}},{"id":1297431,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-23T00:48:11.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11810,"price":1.39,"value":16415.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":685074,"source":{"system":"sec-edgar","filing":"0001610717-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000013/form4.xml","form_type":"4"}},{"id":1303363,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:21:01.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 10, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":575000,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001610717-25-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000011/form4.xml","form_type":"4"}},{"id":1307868,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-08T01:52:26.000Z","date":"2025-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11810,"price":1.66,"value":19604.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":696884,"source":{"system":"sec-edgar","filing":"0001610717-25-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000009/form4.xml","form_type":"4"}},{"id":1449296,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T00:16:42.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":196500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 982,500 shares of common stock, of which 196,500 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise."}],"balance_after":196500,"derivative":{"exercise_price":2.41,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":196500},"source":{"system":"sec-edgar","filing":"0001610717-24-000406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000406/form4.xml","form_type":"4"}},{"id":1672936,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-24T01:07:16.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11218,"price":2.44,"value":27371.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":708694,"source":{"system":"sec-edgar","filing":"0001610717-24-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000039/form4.xml","form_type":"4"}},{"id":1684077,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-09T00:04:08.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 5, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":575000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-05","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001610717-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000019/form4.xml","form_type":"4"}},{"id":1684076,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-09T00:04:08.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11781,"price":2.92,"value":34400.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":719912,"source":{"system":"sec-edgar","filing":"0001610717-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000019/form4.xml","form_type":"4"}},{"id":1730235,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-24T21:04:59.000Z","date":"2023-11-22","kind":"exercise","planned":false,"acquired":false,"shares":299940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The underlying shares subject to the option vested and became exercisable in successive, equal monthly installments over four years measured from July 20, 2013."}],"balance_after":0,"derivative":{"exercise_price":1.417,"expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":299940},"source":{"system":"sec-edgar","filing":"0001610717-23-000363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071723000363/form4.xml","form_type":"4"}},{"id":1730234,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-24T21:04:59.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":223100,"price":2.016,"value":449769.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $2.000 to $2.055. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":731693,"source":{"system":"sec-edgar","filing":"0001610717-23-000363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071723000363/form4.xml","form_type":"4"}},{"id":1730233,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-24T21:04:59.000Z","date":"2023-11-22","kind":"exercise","planned":false,"acquired":true,"shares":258940,"price":1.417,"value":366917.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person."}],"balance_after":954793,"source":{"system":"sec-edgar","filing":"0001610717-23-000363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071723000363/form4.xml","form_type":"4"}},{"id":1730232,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-24T21:04:59.000Z","date":"2023-11-22","kind":"exercise","planned":false,"acquired":true,"shares":41000,"price":1.417,"value":58097.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"For part of the stock option, this represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price and anticipated taxes."}],"balance_after":695853,"source":{"system":"sec-edgar","filing":"0001610717-23-000363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071723000363/form4.xml","form_type":"4"}},{"id":1854180,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T20:42:44.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001610717-23-000168","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071723000168/form4.xml","form_type":"4"}},{"id":2047395,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-24T21:50:08.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":86250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":654853,"source":{"system":"sec-edgar","filing":"0001567619-23-001211","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761923001211/doc1.xml","form_type":"4"}},{"id":2060268,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T23:17:58.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":402500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":402500,"derivative":{"exercise_price":10.37,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001567619-23-000698","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761923000698/doc1.xml","form_type":"4"}},{"id":2060267,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-06T23:17:58.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":10905,"price":9.87,"value":107632.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":568603,"source":{"system":"sec-edgar","filing":"0001567619-23-000698","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761923000698/doc1.xml","form_type":"4"}},{"id":2066953,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-04T23:44:20.000Z","date":"2022-12-30","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":432684,"source":{"system":"sec-edgar","filing":"0001567619-23-000350","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761923000350/doc1.xml","form_type":"4"}},{"id":2441298,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-07T00:50:59.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":402500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":402500,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001567619-22-000821","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761922000821/doc1.xml","form_type":"4"}},{"id":2441297,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-07T00:50:59.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":86250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,250 RSUs."}],"balance_after":579508,"source":{"system":"sec-edgar","filing":"0001567619-22-000821","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761922000821/doc1.xml","form_type":"4"}},{"id":2497619,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-23T22:00:15.000Z","date":"2021-11-17","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift for charitable purposes of 10,000 shares of the Company's Common Stock to a private trust. The private trust is not owned or controlled by the Reporting Person or the Reporting Person's family members and no compensation was received in return for the gift of the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":436684,"source":{"system":"sec-edgar","filing":"0001567619-21-021059","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921021059/doc1.xml","form_type":"4"}},{"id":2677389,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T21:11:36.000Z","date":"2021-06-08","kind":"exercise","acquired":false,"shares":31054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0.4168,"expiration_date":"2021-07-17","underlying":"Common Stock","underlying_shares":31054},"source":{"system":"sec-edgar","filing":"0001567619-21-011842","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921011842/doc1.xml","form_type":"4"}},{"id":2677388,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T21:11:36.000Z","date":"2021-06-06","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":31054,"derivative":{"exercise_price":0.4168,"expiration_date":"2021-07-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567619-21-011842","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921011842/doc1.xml","form_type":"4"}},{"id":2677387,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-08T21:11:36.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":31054,"price":13.5644,"value":421228.8776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $13.55 to $13.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":493258,"source":{"system":"sec-edgar","filing":"0001567619-21-011842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921011842/doc1.xml","form_type":"4"}},{"id":2677386,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-08T21:11:36.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":31054,"price":0.4168,"value":12943.3072,"ownership":{"direct":true},"balance_after":524312,"source":{"system":"sec-edgar","filing":"0001567619-21-011842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921011842/doc1.xml","form_type":"4"}},{"id":2677385,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-08T21:11:36.000Z","date":"2021-06-06","kind":"exercise","acquired":true,"shares":300000,"price":0.4168,"value":125040.0,"ownership":{"direct":true},"balance_after":493258,"source":{"system":"sec-edgar","filing":"0001567619-21-011842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921011842/doc1.xml","form_type":"4"}},{"id":2881455,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T22:38:20.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 23, 2021, the board of directors of Coherus BioSciences, Inc. approved the grant of an option to purchase 125,000 shares of common stock subject to the achievement of a certain performance milestone. 100% of the shares underlying this option were fully vested and exercisable at grant."}],"balance_after":125000,"derivative":{"exercise_price":17.6,"exercise_date":"2021-02-01","expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001567619-21-002142","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921002142/doc1.xml","form_type":"4"}},{"id":2895057,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:37:41.000Z","date":"2021-01-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 23, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":18.33,"expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-21-001529","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761921001529/doc1.xml","form_type":"4"}},{"id":3088649,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T21:58:09.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":29994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0.0083,"expiration_date":"2020-10-11","underlying":"Common Stock","underlying_shares":29994},"source":{"system":"sec-edgar","filing":"0001567619-20-012977","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761920012977/doc1.xml","form_type":"4"}},{"id":3088648,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-06T21:58:09.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":29994,"price":0.0083,"value":248.9502,"ownership":{"direct":true},"balance_after":193258,"source":{"system":"sec-edgar","filing":"0001567619-20-012977","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761920012977/doc1.xml","form_type":"4"}},{"id":3311532,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T22:50:30.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-20-001041","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761920001041/doc1.xml","form_type":"4"}},{"id":3311531,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T22:50:30.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":21516,"price":17.73,"value":381478.68,"ownership":{"direct":true},"balance_after":163264,"source":{"system":"sec-edgar","filing":"0001567619-20-001041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761920001041/doc1.xml","form_type":"4"}},{"id":3311530,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T22:50:30.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":59763,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":184780,"source":{"system":"sec-edgar","filing":"0001567619-20-001041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761920001041/doc1.xml","form_type":"4"}},{"id":3359881,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-25T21:03:05.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":12500,"price":18.5568,"value":231960.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $18.39 to $18.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":446684,"source":{"system":"sec-edgar","filing":"0001567619-19-022189","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761919022189/doc1.xml","form_type":"4"}},{"id":3361176,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-22T23:56:26.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":825000,"price":18,"value":14850000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is selling the shares to an existing stockholder, V-Sciences Investments Pte Ltd., in a private transaction at a purchase price of $18 per share.  The sale will be effected in two tranches as follows: (i) 470,000 shares will be sold on November 22, 2019 and (ii) 355,000 shares will be sold on the third business day following the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":459184,"source":{"system":"sec-edgar","filing":"0001567619-19-022127","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761919022127/doc1.xml","form_type":"4"}},{"id":3506203,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-01T00:46:13.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":32398,"price":19.4852,"value":631281.5096,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $19.37 to $19.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":1284184,"source":{"system":"sec-edgar","filing":"0001567619-19-012553","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000156761919012553/doc1.xml","form_type":"4"}},{"id":3695461,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option\n(Right to Buy)","published_at":"2019-01-15T21:07:17.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":450000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000899243-19-001204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924319001204/doc4.xml","form_type":"4"}},{"id":3695460,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T21:07:17.000Z","date":"2019-01-11","kind":"tax_withholding","acquired":false,"shares":17867,"price":12.37,"value":221014.79,"ownership":{"direct":true},"balance_after":125017,"source":{"system":"sec-edgar","filing":"0000899243-19-001204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924319001204/doc4.xml","form_type":"4"}},{"id":3695459,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T21:07:17.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":50265,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":142884,"source":{"system":"sec-edgar","filing":"0000899243-19-001204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924319001204/doc4.xml","form_type":"4"}},{"id":3927832,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-05-17T21:59:50.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":20984,"price":16.2631,"value":341264.8904,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $16.00 to $16.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":1316582,"source":{"system":"sec-edgar","filing":"0000899243-18-013275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924318013275/doc4.xml","form_type":"4"}},{"id":4076151,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:05:39.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-18-002883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924318002883/doc4.xml","form_type":"4"}},{"id":4126277,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-12-19T21:05:45.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":20984,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92619,"source":{"system":"sec-edgar","filing":"0000899243-17-029150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924317029150/doc4.xml","form_type":"4"}},{"id":4240009,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-08T20:05:17.000Z","date":"2017-08-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the \"Vesting Commencement Date\"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-17-019839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924317019839/doc4.xml","form_type":"4"}},{"id":4597081,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-22T20:07:21.000Z","date":"2016-09-21","kind":"sale","acquired":false,"shares":50,"price":31.75,"value":1587.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":1337566,"source":{"system":"sec-edgar","filing":"0000899243-16-029739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924316029739/doc4.xml","form_type":"4"}},{"id":4597080,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-22T20:07:21.000Z","date":"2016-09-20","kind":"sale","acquired":false,"shares":4010,"price":31.7512,"value":127322.312,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $31.75 to $31.76, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":1337616,"source":{"system":"sec-edgar","filing":"0000899243-16-029739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924316029739/doc4.xml","form_type":"4"}},{"id":4598986,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-20T20:05:49.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":2900,"price":31.7928,"value":92199.12,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $31.75 to $31.84, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee."}],"balance_after":1341626,"source":{"system":"sec-edgar","filing":"0000899243-16-029405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000089924316029405/doc4.xml","form_type":"4"}}]}